GR
Grown Rogue International Inc.
GRUSF · OTC
$0.43 +3.06% (+$0.01)
1M -10.75%
Market Cap $105.2M
P/E Ratio -
Div. Yield -
ROE 30.15%
Bulios Fair Price
$0.42
3.2% downside
Current Price
$0.43
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GRUSF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
11 /100
Expensive EV/EBITDA 31.63x
P/FCF 523.47x
P/S 2.79x
Growth
78 /100
Growing EPS growth 114.33%
Book val. growth 64.17%
Rev. growth 22.94%
Profitability
31 /100
Weak Gross margin 43.92%
FCF margin 0.53%
Net margin 16.74%
Quality
28 /100
Poor ROIC 9.31%
Asset turnover 0.58x
ROE 30.15%
Debt
31 /100
High Debt/Equity 1.79x
Net debt/EBITDA 4.14x
Current ratio 2.59x
Stability
46 /100
Moderate Beta -1.04x
Profitable years 1
Rev. volatility 0.82%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GRUSF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
J. Obie Strickler
Employees
204
Headquarters
Medford
Upcoming events
18 NOV
Earnings
Upcoming earnings report
06 APR
Earnings
Upcoming earnings report